T, S., D, S., ER, P., BJ, G., DR, M., U, S., . . . NA, C. (2022). Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with improved perioperative outcomes: A single-center early experience propensity-matched analysis. Surgical endoscopy, 36(8), 6153. https://doi.org/10.1007/s00464-022-09034-y
Chicago Style (17th ed.) CitationT, Shaltiel, Solomon D, Pletcher ER, Golas BJ, Magge DR, Sarpel U, Labow DM, and Cohen NA. "Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Associated with Improved Perioperative Outcomes: A Single-center Early Experience Propensity-matched Analysis." Surgical Endoscopy 36, no. 8 (2022): 6153. https://doi.org/10.1007/s00464-022-09034-y.
MLA (9th ed.) CitationT, Shaltiel, et al. "Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Associated with Improved Perioperative Outcomes: A Single-center Early Experience Propensity-matched Analysis." Surgical Endoscopy, vol. 36, no. 8, 2022, p. 6153, https://doi.org/10.1007/s00464-022-09034-y.